Health
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345) – Business Wire
Moderna receives FDA Fast Track designation for Respiratory Syncytial Virus (RSV) vaccine (mRNA-1345).
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for mRNA-1345,…
Continue Reading
-
Noosa News8 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News14 hours agoLarge fleet of Robinson R22 helicopters sold as HM Air flies in another direction
-
General6 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News7 hours agoLyka Doggie Date Night at Moonlight Cinema